New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
14:35 EDTMNK, ACTActavis' generic version of Exalgo approved by FDA
The FDA approved Actavisí (ACT) generic version of hydromorphone hydrochloride in strengths of 8 mg, 12 mg and 16 mg on May 12, according to a post to the FDA website. Hydromorphone hydrochloride is sold in branded form under the name Exalgo by Mallinckrodt (MNK). Reference Link
News For MNK;ACT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
16:57 EDTMNKHikma, Mallinckrodt among bidders for Roxane Labs, Bloomberg says
Hikma (HKMPY) and Mallinckrodt (MNK) are bidding for Boehringer's Roxane Labs business, reports Bloomberg, citing people with knowledge of the matter. Roxane Labs could end up being purchased for over $2.2B, Bloomberg adds. Reference Link
15:01 EDTMNKMallinckrodt, Perrigo among bidders for Roxane Labs, Bloomberg reports
Mallinckrodt (MNK), Perrigo (PRGO) and Hikma are among the potential bidders for Boehringer Ingelheim's Roxane Labs generic business, said Bloomberg, citing people with knowledge of the matter.
June 23, 2015
11:12 EDTMNKMallinckrodt management to meet with Guggenheim
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use